Eton Pharmaceuticals (ETON) Research & Development (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Research & Development of $1.8 million for Q4 2025, up 60.07% sequentially from $1.1 million in Q3 2025, and up 304.36% YoY from $440198.8 in Q4 2024.
Eton Pharmaceuticals (ETON) Research & Development (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Research & Development for 8 years, with the latest figure at $1.8 million in Q4 2025.
- Quarterly Research & Development rose 304.36% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (up 138.56% YoY) and the FY2025 annual result came in at $7.8 million, up 138.56% from the prior year.
- Research & Development rose to $1.8 million in Q4 2025 per ETON's latest filing, from $1.1 million in the prior quarter.
- Over five years, Research & Development peaked at $3.7 million in Q2 2025 and troughed at -$871000.0 in Q4 2024.
- A 5-year average of $1.2 million and a median of $995500.0 in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development tumbled 183.19% in 2024, then soared 304.36% in 2025.
- Over 5 years, Research & Development stood at $681000.0 in 2021, then jumped by 38.62% to $944000.0 in 2022, then gained by 10.91% to $1.0 million in 2023, then sank by 183.19% to -$871000.0 in 2024, then jumped by 304.36% to $1.8 million in 2025.
- According to Business Quant data, Research & Development over the past three periods registered $1.8 million, $1.1 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 993,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 993,000.00 |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | -871,000.00 |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 651,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 615,000.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 744,000.00 |
| Jun 30, 2022 | 690,000.00 |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 681,000.00 |
| Sep 30, 2021 | 2.68 Mn |
| Jun 30, 2021 | 1.99 Mn |